» Articles » PMID: 31013367

Rare Cancers in Childhood and Adolescence in Brazil: First Report of Data from 19 Population-based Cancer Registries

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2019 Apr 24
PMID 31013367
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rare childhood cancer is challenging to define. The Italian Pediatric Rare Tumor (TREP) Study considers rare tumors to include solid malignancies characterized by an annual incidence rate of <2 cases per 1 million and not enrolled in clinical trials. The objective of the current study was to analyze the population incidence rate of rare tumors among children and adolescents (those aged birth-19 years) in Brazil.

Methods: Incidence data were obtained from 19 population-based cancer registries covering the 5 geographic regions in Brazil. Newly diagnosed cases were selected according to the TREP definition, using the International Classification of Diseases for Oncology. To calculate the crude incidence rate, the numbers of incident children and adolescents with a specific rare cancer were divided by the corresponding person-years lived for the population aged <20 years during the same period.

Results: Two tumors had an incidence rate that was >2 cases per 1 million (thyroid and skin cancers) in adolescents only. Several tumors demonstrated variations in incidence across the Brazilian regions. Adrenocortical carcinoma had a high incidence rate (4 cases per 1 million) in the south region among children aged <10 years. Thyroid and skin carcinoma had higher incidence rates in the midwest, southeast, and south regions.

Conclusions: Due to the extraordinary rarity of these events, networking is important for improving basic research, clinical studies, and trials. Centralization of diagnosis is the only way to improve the diagnosis and treatment of children affected by these rare diseases. The registration and surveillance of rare pediatric cancers are crucial from a public health point of view, and therefore the quality of registration has to be improved.

Citing Articles

Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients.

Garcia Alves-Junior P, Barreto M, de Andrade F, Bulzico D, Corbo R, Vaisman F Endocrine. 2024; 84(3):1081-1087.

PMID: 38296913 DOI: 10.1007/s12020-024-03691-w.


Case Report: Adrenocortical carcinoma in children-symptoms, diagnosis, and treatment.

Zagojska E, Malka M, Gorecka A, Ben-Skowronek I Front Endocrinol (Lausanne). 2023; 14:1216501.

PMID: 38075063 PMC: 10702754. DOI: 10.3389/fendo.2023.1216501.


Epidemiology of rare diseases in Brazil: protocol of the Brazilian Rare Diseases Network (RARAS-BRDN).

Felix T, de Oliveira B, Artifon M, Carvalho I, Bernardi F, Schwartz I Orphanet J Rare Dis. 2022; 17(1):84.

PMID: 35209917 PMC: 8867447. DOI: 10.1186/s13023-022-02254-4.


Adrenocortical Carcinoma: Updates of Clinical and Pathological Features after Renewed World Health Organisation Classification and Pathology Staging.

Lam A Biomedicines. 2021; 9(2).

PMID: 33578929 PMC: 7916702. DOI: 10.3390/biomedicines9020175.


Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries.

de Souza Reis R, Gatta G, de Camargo B PLoS One. 2020; 15(5):e0232416.

PMID: 32357198 PMC: 7194432. DOI: 10.1371/journal.pone.0232416.